Association of C4d Deposition with Clinical Outcomes in IgA Nephropathy

Adult Male Biopsy Kaplan-Meier Estimate Kidney survival End Stage Liver Disease 03 medical and health sciences 0302 clinical medicine Complement C4b Humans complement Retrospective Studies Hypertelorism Glomerulonephritis, IGA IgA nephropathy Middle Aged Prognosis Immunohistochemistry Peptide Fragments 3. Good health Proteinuria Mesangial Cells Disease Progression Female Glomerular Filtration Rate
DOI: 10.2215/cjn.09710913 Publication Date: 2014-02-28T05:40:59Z
ABSTRACT
Several studies have suggested that activation of the complement system is a contributing pathogenic mechanism in IgA nephropathy (IgAN). C4d staining an inexpensive and easy-to-perform method for analysis renal biopsies. This study aimed to assess clinical prognostic implications IgAN.This retrospective cohort included 283 patients with IgAN 11 hospitals Spain who underwent biopsy between 1979 2010. The primary predictor was mesangial staining. Secondary predictors demographic, clinical, laboratory characteristics, Oxford pathologic classification criteria. end point cumulative percentage developed ESRD, defined as onset chronic dialysis or transplantation. analyzed by immunohistochemical using polyclonal antibody. Kaplan-Meier Cox proportional hazards analyses were performed evaluate effect on survival.There 109 (38.5%) 174 (61.5%) classified positive negative, respectively. Renal survival at 20 years 28% C4d-positive versus 85% C4d-negative (P<0.001). Independent risk factors associated ESRD follows: proteinuria (hazard ratio [HR] per every 1 g/d increase. 1.16; 95% confidence interval [95% CI], 1.03 1.31; P=0.01), eGFR (HR ml/min 1.73 m(2) increase, 0.96; CI, 0.94 0.97; P<0.001), T2 (tubular atrophy/interstitial fibrosis, >50%; HR, 4.42; 1.40 13.88; (HR, 2.45; 1.30 4.64; P=0.01).C4d-positive independent factor development IgAN. finding consistent possibility involved pathogenesis this disease.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (36)
CITATIONS (176)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....